Royalty Pharma (RPRX) Dividend Coverage Ratio Growth (3y) (2022 - 2026)
Powered by 
Analysis
Royalty Pharma (RPRX) Dividend Coverage Ratio Growth (3y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -41.07% |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.57 Bn | 21.04 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -41.07% |
| Mar 31, 2026 | -8.34% |
| Dec 31, 2025 | 35.26% |
| Sep 30, 2025 | 31.43% |
| Jun 30, 2025 | -43.06% |
| Mar 31, 2025 | 29.56% |
| Dec 31, 2024 | 262.41% |
| Sep 30, 2024 | 144.97% |
| Jun 30, 2024 | -4.05% |
| Mar 31, 2024 | -28.17% |
| Dec 31, 2023 | 192.29% |
| Sep 30, 2023 | -9.91% |
| Jun 30, 2023 | 33.03% |
| Mar 31, 2023 | 182.53% |
| Dec 31, 2022 | -35.19% |
| Sep 30, 2022 | -20.19% |